Equities Analysts Set Expectations for ARWR FY2025 Earnings
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities researchers at Cantor Fitzgerald upped their FY2025 earnings per share estimates for shares of Arrowhead Pharmaceuticals in a research note issued on Tuesday, May 13th. Cantor Fitzgerald analyst P. Agrawal now expects that the biotechnology company will earn ($0.54) per share for the year, up from […]
